{"transactions":[{"id":712550,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-09T00:18:34.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":9386,"price":8.263,"value":77556.518,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."}],"balance_after":230637,"source":{"system":"sec-edgar","filing":"0001437749-26-023077","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926023077/rdgdoc.xml","form_type":"4"}},{"id":890532,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-21T01:28:04.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":66541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to the Reporting Person's  continued service with the Company through the applicable vesting date."}],"balance_after":66541,"derivative":{"exercise_price":6.68,"expiration_date":"2036-02-17","underlying":"Common Stock","underlying_shares":66541},"source":{"system":"sec-edgar","filing":"0001437749-26-004946","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926004946/rdgdoc.xml","form_type":"4"}},{"id":890531,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-21T01:28:04.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":46739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service with the Company through the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service with the Company through the applicable vesting date."}],"balance_after":240023,"source":{"system":"sec-edgar","filing":"0001437749-26-004946","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926004946/rdgdoc.xml","form_type":"4"}},{"id":943128,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-09T01:14:50.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":6405,"price":5.879,"value":37654.995,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-14-2020"}],"balance_after":193284,"source":{"system":"sec-edgar","filing":"0001437749-26-000921","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926000921/rdgdoc.xml","form_type":"4"}},{"id":943127,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-09T01:14:50.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":4540,"price":5.844,"value":26531.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-14-2020"}],"balance_after":199689,"source":{"system":"sec-edgar","filing":"0001437749-26-000921","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926000921/rdgdoc.xml","form_type":"4"}},{"id":1089226,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-11T00:56:09.000Z","date":"2025-07-09","kind":"sale","planned":true,"acquired":false,"shares":3935,"price":3.535,"value":13910.225,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-14-2020"}],"balance_after":204229,"source":{"system":"sec-edgar","filing":"0001437749-25-022551","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925022551/rdgdoc.xml","form_type":"4"}},{"id":1089225,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-11T00:56:09.000Z","date":"2025-07-08","kind":"sale","planned":true,"acquired":false,"shares":5587,"price":3.533,"value":19738.871,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-14-2020"}],"balance_after":208164,"source":{"system":"sec-edgar","filing":"0001437749-25-022551","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925022551/rdgdoc.xml","form_type":"4"}},{"id":1273702,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T23:58:40.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":85067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Optionee's continued service with the Company through the applicable vesting date."}],"balance_after":85067,"derivative":{"exercise_price":2.78,"expiration_date":"2035-02-06","underlying":"Common Stock","underlying_shares":85067},"source":{"system":"sec-edgar","filing":"0001437749-25-003461","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925003461/rdgdoc.xml","form_type":"4"}},{"id":1273701,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-11T23:58:40.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":61456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Grantee's continued service with the Company through the applicable vesting date."}],"balance_after":213751,"source":{"system":"sec-edgar","filing":"0001437749-25-003461","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925003461/rdgdoc.xml","form_type":"4"}},{"id":1314223,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-04T00:33:40.000Z","date":"2025-01-02","kind":"sale","planned":true,"acquired":false,"shares":10227,"price":3.1517,"value":32232.4359,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.2101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":152295,"source":{"system":"sec-edgar","filing":"0001437749-25-000365","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925000365/rdgdoc.xml","form_type":"4"}},{"id":1451727,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-18T23:11:49.000Z","date":"2024-07-17","kind":"sale","planned":true,"acquired":false,"shares":4156,"price":3.7011,"value":15381.7716,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6001 to $3.8901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":162522,"source":{"system":"sec-edgar","filing":"0001437749-24-023022","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924023022/rdgdoc.xml","form_type":"4"}},{"id":1462606,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T01:22:50.000Z","date":"2024-07-02","kind":"sale","planned":true,"acquired":false,"shares":5295,"price":3.2685,"value":17306.7075,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2601 to $3.3101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":166678,"source":{"system":"sec-edgar","filing":"0001437749-24-022067","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924022067/rdgdoc.xml","form_type":"4"}},{"id":1642898,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-14T23:01:43.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":59946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date."}],"balance_after":59946,"derivative":{"exercise_price":6.36,"expiration_date":"2034-02-11","underlying":"Common Stock","underlying_shares":59946},"source":{"system":"sec-edgar","filing":"0001437749-24-004216","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924004216/rdgdoc.xml","form_type":"4"}},{"id":1642897,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-14T23:01:43.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":43307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date."}],"balance_after":171973,"source":{"system":"sec-edgar","filing":"0001437749-24-004216","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924004216/rdgdoc.xml","form_type":"4"}},{"id":1685388,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-05T23:49:52.000Z","date":"2024-01-03","kind":"sale","planned":true,"acquired":false,"shares":15682,"price":4.4859,"value":70347.8838,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.3601 to $4.7101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":128666,"source":{"system":"sec-edgar","filing":"0001437749-24-000768","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924000768/rdgdoc.xml","form_type":"4"}},{"id":1833657,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-06T23:12:42.000Z","date":"2023-07-03","kind":"sale","planned":true,"acquired":false,"shares":14680,"price":3.3112,"value":48608.416,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.24 to $3.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":144348,"source":{"system":"sec-edgar","filing":"0001437749-23-019525","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923019525/rdgdoc.xml","form_type":"4"}},{"id":2015938,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-14T21:53:27.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":81399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2023, January 1, 2024, July 1, 2024 and January 1, 2025, subject to the Optionee's continued service with the Company through the applicable vesting date."}],"balance_after":81399,"derivative":{"exercise_price":4.39,"expiration_date":"2033-02-09","underlying":"Common Stock","underlying_shares":81399},"source":{"system":"sec-edgar","filing":"0001437749-23-003382","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923003382/rdgdoc.xml","form_type":"4"}},{"id":2015937,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-02-14T21:53:27.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":58601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2023, January 1, 2024, July 1, 2024 and January 1, 2025, subject to the Grantee's continued service with the Company through the applicable vesting date."}],"balance_after":159028,"source":{"system":"sec-edgar","filing":"0001437749-23-003382","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923003382/rdgdoc.xml","form_type":"4"}},{"id":2062254,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-05T22:40:21.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":10499,"price":4.1779,"value":43863.7721,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.13 to $4.1922, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":100427,"source":{"system":"sec-edgar","filing":"0001437749-23-000547","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774923000547/rdgdoc.xml","form_type":"4"}},{"id":2094338,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-06T21:30:03.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":159,"price":4.4978,"value":715.1502,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.4601 to $4.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":110926,"source":{"system":"sec-edgar","filing":"0001437749-22-028558","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922028558/rdgdoc.xml","form_type":"4"}},{"id":2124315,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-04T20:13:29.000Z","date":"2022-11-02","kind":"sale","acquired":false,"shares":163,"price":2.25,"value":366.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program."}],"balance_after":111085,"source":{"system":"sec-edgar","filing":"0001437749-22-026032","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922026032/rdgdoc.xml","form_type":"4"}},{"id":2142096,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-10-05T20:40:43.000Z","date":"2022-10-03","kind":"sale","acquired":false,"shares":165,"price":2.3354,"value":385.341,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.33 to $2.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":111248,"source":{"system":"sec-edgar","filing":"0001437749-22-023679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922023679/rdgdoc.xml","form_type":"4"}},{"id":2164083,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-07T20:44:44.000Z","date":"2022-09-02","kind":"sale","acquired":false,"shares":164,"price":2.5896,"value":424.6944,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.565 to $2.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":111413,"source":{"system":"sec-edgar","filing":"0001437749-22-021986","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922021986/rdgdoc.xml","form_type":"4"}},{"id":2194383,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-05T01:34:38.000Z","date":"2022-08-02","kind":"sale","acquired":false,"shares":161,"price":2.89,"value":465.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program."}],"balance_after":111577,"source":{"system":"sec-edgar","filing":"0001437749-22-018993","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922018993/rdgdoc.xml","form_type":"4"}},{"id":2194382,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-05T01:30:44.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":9328,"price":2.6315,"value":24546.632,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.60 to $2.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":111738,"source":{"system":"sec-edgar","filing":"0001437749-22-018991","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922018991/rdgdoc.xml","form_type":"4/A","original_submission_date":"2022-07-07"}},{"id":2210671,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-07-08T00:19:05.000Z","date":"2022-07-05","kind":"sale","acquired":false,"shares":5835,"price":2.6315,"value":15354.8025,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.60 to $2.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":64625,"source":{"system":"sec-edgar","filing":"0001437749-22-016850","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922016850/rdgdoc.xml","form_type":"4"}},{"id":2242155,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-06T21:05:49.000Z","date":"2022-06-02","kind":"sale","acquired":false,"shares":162,"price":1.9218,"value":311.3316,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program."}],"balance_after":121066,"source":{"system":"sec-edgar","filing":"0001437749-22-014434","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922014434/rdgdoc.xml","form_type":"4"}},{"id":2282087,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-04T22:43:49.000Z","date":"2022-05-03","kind":"sale","acquired":false,"shares":165,"price":2.3401,"value":386.1165,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program."}],"balance_after":121228,"source":{"system":"sec-edgar","filing":"0001437749-22-010926","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922010926/rdgdoc.xml","form_type":"4"}},{"id":2304030,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-05T20:52:15.000Z","date":"2022-04-04","kind":"sale","acquired":false,"shares":206,"price":3.078,"value":634.068,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units"}],"balance_after":121393,"source":{"system":"sec-edgar","filing":"0001437749-22-008328","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922008328/rdgdoc.xml","form_type":"4"}},{"id":2335255,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-14T23:31:12.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":88824,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Optionee's continued service with the Company through the applicable vesting date, the Option shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares subject thereto on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024."}],"balance_after":88824,"derivative":{"exercise_price":2.33,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":88824},"source":{"system":"sec-edgar","filing":"0001437749-22-006188","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922006188/rdgdoc.xml","form_type":"4"}},{"id":2335254,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-14T23:31:12.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":62176,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the Grantee's continued service with the Company through the applicable vesting date, the Restricted Stock Units shall vest with respect to one-fourth (1/4th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024."}],"balance_after":121599,"source":{"system":"sec-edgar","filing":"0001437749-22-006188","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922006188/rdgdoc.xml","form_type":"4"}},{"id":2350051,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-04T22:14:48.000Z","date":"2022-03-02","kind":"sale","acquired":false,"shares":169,"price":2.262,"value":382.278,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":59423,"source":{"system":"sec-edgar","filing":"0001437749-22-005306","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922005306/rdgdoc.xml","form_type":"4"}},{"id":2413476,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-02-03T22:34:56.000Z","date":"2022-02-02","kind":"sale","acquired":false,"shares":199,"price":2.4822,"value":493.9578,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":59592,"source":{"system":"sec-edgar","filing":"0001437749-22-002412","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922002412/rdgdoc.xml","form_type":"4"}},{"id":2443472,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-01-05T22:04:44.000Z","date":"2022-01-03","kind":"sale","acquired":false,"shares":7484,"price":3.1896,"value":23870.9664,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.17 to $3.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":59791,"source":{"system":"sec-edgar","filing":"0001437749-22-000444","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774922000444/rdgdoc.xml","form_type":"4"}},{"id":2483608,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-06T23:37:22.000Z","date":"2021-12-02","kind":"sale","acquired":false,"shares":162,"price":2.95,"value":477.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":67275,"source":{"system":"sec-edgar","filing":"0001437749-21-027954","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774921027954/rdgdoc.xml","form_type":"4"}},{"id":2525959,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-11-03T22:22:56.000Z","date":"2021-11-02","kind":"sale","acquired":false,"shares":156,"price":5.671,"value":884.676,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":67437,"source":{"system":"sec-edgar","filing":"0001209191-21-062788","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121062788/doc4.xml","form_type":"4"}},{"id":2547067,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-10-06T21:20:27.000Z","date":"2021-10-04","kind":"sale","acquired":false,"shares":161,"price":6.2001,"value":998.2161,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":67593,"source":{"system":"sec-edgar","filing":"0001437749-21-023380","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774921023380/rdgdoc.xml","form_type":"4"}},{"id":2578969,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2021-09-03T23:40:20.000Z","date":"2021-09-02","kind":"sale","acquired":false,"shares":155,"price":7.511,"value":1164.205,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":67754,"source":{"system":"sec-edgar","filing":"0001209191-21-054896","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121054896/doc4.xml","form_type":"4"}},{"id":2617404,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2021-08-03T21:52:08.000Z","date":"2021-08-02","kind":"sale","acquired":false,"shares":154,"price":7.5421,"value":1161.4834,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":67909,"source":{"system":"sec-edgar","filing":"0001209191-21-049435","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121049435/doc4.xml","form_type":"4"}},{"id":2640942,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2021-07-06T21:43:28.000Z","date":"2021-07-02","kind":"sale","acquired":false,"shares":155,"price":9.2588,"value":1435.114,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units,"}],"balance_after":68063,"source":{"system":"sec-edgar","filing":"0001209191-21-045599","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121045599/doc4.xml","form_type":"4"}},{"id":2680772,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2021-06-04T20:56:37.000Z","date":"2021-06-02","kind":"sale","acquired":false,"shares":152,"price":10.741,"value":1632.632,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":68218,"source":{"system":"sec-edgar","filing":"0001209191-21-038294","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121038294/doc4.xml","form_type":"4"}},{"id":2726974,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2021-05-05T20:44:38.000Z","date":"2021-05-03","kind":"sale","acquired":false,"shares":152,"price":9.9104,"value":1506.3808,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":68370,"source":{"system":"sec-edgar","filing":"0001209191-21-030355","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121030355/doc4.xml","form_type":"4"}},{"id":2755631,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2021-04-06T22:02:16.000Z","date":"2021-04-05","kind":"sale","acquired":false,"shares":155,"price":9.8029,"value":1519.4495,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":68522,"source":{"system":"sec-edgar","filing":"0001209191-21-025730","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121025730/doc4.xml","form_type":"4"}},{"id":2808544,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2021-03-04T21:48:33.000Z","date":"2021-03-02","kind":"sale","acquired":false,"shares":154,"price":10.1356,"value":1560.8824,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":68677,"source":{"system":"sec-edgar","filing":"0001209191-21-017852","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121017852/doc4.xml","form_type":"4"}},{"id":2845908,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-19T23:49:50.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":78209,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Optionee's continued service with the Company through the applicable vesting date, the Option shall vest and become exercisable with respect to (i) one-third (1/3) of the Shares (as defined in the Plan) underlying the Option on the first anniversary of the vesting commencement date of January 1, 2021 (the \"Vesting Commencement Date\") and (ii) one-sixth (1/6th) of the Shares subject thereto on each of July 1, 2022, January 1, 2023, July 1, 2023, and January 1, 2024."}],"balance_after":78209,"derivative":{"exercise_price":12.02,"expiration_date":"2031-02-16","underlying":"COMMON STOCK","underlying_shares":78209},"source":{"system":"sec-edgar","filing":"0001209191-21-012533","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121012533/doc4.xml","form_type":"4"}},{"id":2845907,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2021-02-19T23:49:50.000Z","date":"2021-02-17","kind":"grant","acquired":true,"shares":55595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to the Grantee's continued service with the Company through the applicable vesting date, the Restricted Stock Units shall vest with respect to (i) one-third (1/3) of the Restricted Stock Units on the first anniversary of the vesting commencement date of January 1, 2021 (the \"Vesting Commencement Date\") and (ii) one-sixth (1/6th) of the Restricted Stock Units on each of July 1, 2022, January 1, 2023, July 1, 2023 and January 1, 2024."}],"balance_after":68831,"source":{"system":"sec-edgar","filing":"0001209191-21-012533","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121012533/doc4.xml","form_type":"4"}},{"id":2879079,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2021-02-04T22:13:35.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":179,"price":12.2607,"value":2194.6653,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."}],"balance_after":13236,"source":{"system":"sec-edgar","filing":"0001209191-21-007808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121007808/doc4.xml","form_type":"4"}},{"id":2915228,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2021-01-06T23:48:48.000Z","date":"2021-01-04","kind":"sale","acquired":false,"shares":2145,"price":10.2239,"value":21930.2655,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.17 to $10.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":13415,"source":{"system":"sec-edgar","filing":"0001209191-21-002341","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919121002341/doc4.xml","form_type":"4"}},{"id":3273767,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-14T02:34:37.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":15567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting commencement date of the option is January 1, 2020 (\"Option Vesting Commencement Date\"). The option vests (i) with respect to one-third (1/3rd) of the shares subject thereto on the first anniversary of the Option Vesting Commencement Date and (ii) with respect to 1/36th of the shares subject thereto on each monthly anniversary of the Option Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":15567,"derivative":{"exercise_price":12.34,"expiration_date":"2030-02-10","underlying":"COMMON STOCK","underlying_shares":15567},"source":{"system":"sec-edgar","filing":"0001209191-20-009464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120009464/doc4.xml","form_type":"4"}},{"id":3273766,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"COMMON STOCK","published_at":"2020-02-14T02:34:37.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":15560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units which vest (i) with respect to one-third (1/3rd) of the shares subject thereto on the first anniversary of the vesting commencement date of January 1, 2020 (\"Vesting Commencement Date\") and (ii) with respect to 1/36th of the shares subject thereto on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":15560,"source":{"system":"sec-edgar","filing":"0001209191-20-009464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919120009464/doc4.xml","form_type":"4"}},{"id":3766723,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-14T00:25:04.000Z","date":"2018-11-11","kind":"grant","acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting commencement date (\"Vesting Commencement Date\") of the option is November 11, 2018. The option vests (i) with respect to one-third (1/3) of the shares underlying the option on the first anniversary of the Vesting Commencement Date and (ii) with respect to 1/36th of the shares underlying the option, on each monthly anniversary of the Vesting Commencement Date thereafter, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date."}],"balance_after":90000,"derivative":{"exercise_price":23.37,"expiration_date":"2028-11-10","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001209191-18-058405","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000120919118058405/doc4.xml","form_type":"4"}}]}